[Asia Economy Reporter Minji Lee] Woojung Bio announced on the 14th that it has signed a contract with MD Healthcare to establish a GMP manufacturing facility and an animal testing laboratory. The contract amount is 4.6 billion KRW, accounting for 12% of recent sales. The contract end date is September 13.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing